Furthermore, CD31 + EVs from T2DM patients have been shown to promote the expression of inflammatory mRNAs, such as CCL2, IL-1α, and TNFα, when administered to endothelial cells in vitro, indicating their potential role in mediating inflammation in T2DM [47]. This evidence concerns the gene CCL2 and type 2 diabetes mellitus.